PrimeRFP SCOUT · Federal Contract Recompete Brief

FA238424CB015Non-surgical control of junctional and — Amsel Medical Corp

Amsel Medical Corp holds $5.5M across 2 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Apr 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh

Awarding office

Amsel Medical Corp

Recipient

Apr 29, 2027

PoP end

$5.5M

Obligated

$7.5M

Potential

541715

NAICS

AC12

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amsel Medical Corp — $90

Contract facts

NONE

Contract numberFA238424CB015

AgencyFa2384 Usaf Afmc Afrl Pzl Afrl Rakh

Awarding officeFa2384 Usaf Afmc Afrl Pzl Afrl Rakh

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAmsel Medical Corp

CAGE6PXF8

UEIUUM9WLJWJQ24

NAICS541715

PSCAC12

Place of performanceCAMBRIDGE MA

Pricing typeCost Plus Fixed Fee

Extent competedFull And Open Competition

PoP startSep 30, 2024

PoP end (current)Apr 29, 2027

Obligated$5.5M

Current value$7.5M

Potential value$7.5M

NON-SURGICAL CONTROL OF JUNCTIONAL AND NON-COMPRESSIBLE HEMORRHAGE VIA PERCUTANEOUSLY DELIVERED ADJUSTABLE VESSEL OCCLUSION is a federal NONE award for Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh held by Amsel Medical Corp. Estimated value $7.5M ($5.5M obligated). Current period of performance ends Apr 29, 2027. Last award drew 1 bidder. Place of performance: CAMBRIDGE MA.

NON-SURGICAL CONTROL OF JUNCTIONAL AND NON-COMPRESSIBLE HEMORRHAGE VIA PERCUTANEOUSLY DELIVERED ADJUSTABLE VESSEL OCCLUSION

Recompete timing

Public

● Expiring in 234 days

Current PoP ends Apr 29, 2027 (234 days remaining). Agencies typically plan 12–18 months ahead — at 7.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Amsel Medical Corp — $5.5M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$5.5M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract FA238424CB015?

FA238424CB015 (Non-surgical control of junctional and) is a Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh award with a potential value of $7.5M, currently held by Amsel Medical Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded FA238424CB015?

Fa2384 Usaf Afmc Afrl Pzl Afrl Rakh awarded FA238424CB015 to Amsel Medical Corp (potential $7.5M).

Who is the incumbent on FA238424CB015?

Amsel Medical Corp is the incumbent with $5.5M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Apr 29, 2027.

When does Amsel Medical Corp’s FA238424CB015 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on FA238424CB015 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Feb 24, 2026